Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
2.810
-0.070 (-2.43%)
Jul 20, 2026, 4:10 PM AEST

Mayne Pharma Group Market Cap

Mayne Pharma Group has a market cap or net worth of 228.3 million as of July 20, 2026. Its market cap has decreased by -44.36% in one year.

Market Cap
228.30M
Enterprise Value
203.32M
Revenue
407.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.81

Chart

Chart

Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 228.30M, an increase of 400.01%. That is a compound annual growth rate of 8.81%.

History

DateMarket Cap% Change
Jul 20, 2026228.30M-9.65%
Dec 31, 2025252.67M-37.42%
Dec 31, 2024403.79M-19.19%
Dec 29, 2023499.66M43.60%
Dec 30, 2022347.96M-33.16%
Dec 31, 2021520.63M-10.12%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
CSL Limited59.06B
Sigma Healthcare33.70B
Pro Medicus19.55B
Sonic Healthcare10.81B
Starpharma Holdings299.02M
Healius272.31M
Monash IVF Group268.85M
EBR Systems267.38M
Market Cap Rankings